University of California San Francisco
Give to UCSFNeurologist Bruce Miller, MD, director of the UCSF Memory and Aging Center, participated in a roundtable discussion on Alzheimer’s disease and frontotemporal dementia on the "Charlie Rose Show."
Dogs with spinal cord injuries may soon benefit from an experimental drug being tested by researchers at UCSF and Texas A&M College of Veterinary Medicine & Biomedical Sciences — work that they hope will one day help people with similar injuries.
An experimental drug called Ocrelizumab has shown promise in a Phase 2 clinical trial involving 220 people with multiple sclerosis (MS), an often debilitating, chronic autoimmune disease that affects an increasing number of people in North America.
Patients diagnosed with traumatic brain injury (TBI) had over twice the risk of developing dementia within seven years after diagnosis compared to those without TBI, in a study of more than 280,000 older veterans conducted by researchers at the San Francisco VA Medical Center and UCSF.
<p>UCSF cognitive neuroscientist Adam Gazzaley has used functional brain imaging and EEG studies to discover that older adults fare worse than younger adults at remembering following distractions. He hopes to improve their performance with cognitive training, using a newly developed video game.</p>